Lipcure 40 Tablet contains Atorvastatin 40 mg, a potent lipid-lowering agent belonging to the statin class. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides while increasing high-density lipoprotein cholesterol (HDL-C). Atorvastatin exerts its therapeutic effect by selectively inhibiting HMG-CoA reductase, a key enzyme involved in the biosynthesis of cholesterol in the liver, leading to decreased cholesterol production and enhanced clearance of LDL particles from the bloodstream. Lipicure 40 is prescribed as an adjunct to diet and lifestyle modifications, including exercise and weight control, to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with established coronary heart disease or those at high risk. The tablet is administered orally, typically once daily, with or without food, and dosage adjustments should be based on individual patient response and tolerability. Common adverse effects may include headache, myalgia, and gastrointestinal disturbances, while serious side effects such as myopathy and hepatotoxicity require prompt medical attention. Regular monitoring of lipid profiles, liver function tests, and creatine kinase levels is recommended during therapy to ensure safety and efficacy.